Procter & Gamble is about to report earnings. Here’s what to expect

Procter & Gamble is about to report earnings. Here’s what to expect


Tide laundry detergent is shown on display in Compton, California, U.S., January 10, 2017. 

Mike Blake | Reuters

Procter & Gamble is expected to report its quarterly earnings before the bell Friday.

Here’s what Wall Street analysts surveyed by Refinitiv are expecting the company to report:

  • Earnings per share: $1.32 expected
  • Revenue: $19.98 billion expected

The company, which makes Tide detergent, Crest toothpaste and Gillette razors, has been raising prices on its goods for nearly two years to mitigate increasing commodity costs. Its prices were up 10% in the company’s fiscal third quarter compared with the year-ago period.

But those higher price tags have had the effect of scaring off customers, who are switching to cheaper private label options or buying those products less often. Last quarter, P&G’s volume fell 3%.

Still, P&G hasn’t seen the same drop in demand in the U.S., its largest market. And China, its second largest market, is bouncing back from a Covid-related slump.

Looking to fiscal 2024, Wall Street is anticipating the company’s earnings per share will grow 8.8% and revenue will increase 4.5%.

P&G shares have risen just 1% this year, giving the company a market value of $361 billion.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More